Vitamin C exerts an anti-inflammatory effect by inhibiting the activation of nuclear factor kappa-B (NF-κB) [14,15], which modulates the transcription of several proinflammatory cytokines that promote antioxidant cellular injury [32] and endothelial dysfunction [33]. The gene discussed is NFKB1; the disease is endothelial dysfunction.